Company / Accounts Receivable
Zai Lab Ltd Accounts Receivable History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$106.1M
FY2025
5-year range
$40.0M / $106.1M
FY2021-FY2025
Trend
+24.6%
vs FY2024
Sector context
#56 of 113
Health Care
What the data says
At $106M, Zai Lab Ltd's accounts receivable ranks #56 of 113 in the Health Care sector. Accounts Receivable has increased for 3 consecutive years, from $40M in FY2022 to $106M in FY2025.
Based on SEC 10-K filings.
$106M in FY2025 with a 5-year CAGR of +83.0%.
Improved from $59M to $106M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +38.5%
- 5-Year CAGR
- +83.0%
- 10-Year CAGR
- -
Sector benchmark
#56 of 113 in Health CareTop 50% of 113This company $106.1M Sector average $1.1B
▼
-90.7% below sector average
Key checks
Key Insights
- Zai Lab Ltd's accounts receivable has grown for 3 consecutive years.
- 5-year CAGR of +83.0%, indicating consistent growth.
- In FY2025, accounts receivable increased 24.6% year-over-year.
- Ranks #56 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $106.1M | +24.6% |
| FY2024 | $85.2M | +43.9% |
| FY2023 | $59.2M | +48.1% |
| FY2022 | $40.0M | -15.8% |
| FY2021 | $47.5M | +819.1% |
| FY2020 | $5.2M | +36.2% |
| FY2019 | $3.8M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026